• Mashup Score: 14

    master trials umbrella trials platform trials basket trials RCT methodology flozins SGLT2 inhibitors NephTrials RENAL LIFECYCLE Dapagliflozin

    Tweet Tweets with this article
    • we will be discussing the RENAL LIFECYCLES and basket trial design in a couple of hours with @RonGansevoort Summary https://t.co/L9NE1TU8lt #VisualAbstract from @deniise_am and @ISNkidneycare SoMe team Follow @manasib33 and #NephTrials for more! https://t.co/TRxPjzDyJ0

  • Mashup Score: 4

    This narrative review describes a new approach to navigation in a challenging landscape of clinical drug development in diabetes. Successful outcome studies in recent years have led to new indications and guidelines in type 2 diabetes, yet the number of clinical trials in diabetes is now declining. This is due to many environmental factors acting in concert, including the prioritisation of…

    Tweet Tweets with this article
    • Interesting review on registry based RCTs via @SVRaoMD & @kamleshkhunti https://t.co/Q7Skjb8Wlf Join us for more in just under an hour #NephTrials https://t.co/diI45IYbYk

  • Mashup Score: 2

    The next #Nephtrials discussion will feature a deep dive into convection/hemodiafiltration, and the ongoing registry based trial, H4RT

    Tweet Tweets with this article
    • 10/10 Final thoughts ✳️ Great trial, evidence that acetazolamide works & can be safely used to ⬆️natriuresis. Acetazolamide status needs to be elevated! 👉 Up next - #NephTrials chat on registry based RCTs with @manasib33 https://t.co/7vUjy9FOsW Tweetorial by @nephrokavitha

  • Mashup Score: 0

    After cluster RCTs and pragmatic trials, we will discuss the role of run in periods and what we try to achieve by having them in clinical trials. Read on. This week we discuss cluster RCTs. How…

    Tweet Tweets with this article
    • New this year was the #NephTrials initiative with @ISNkidneycare with 3 chats on - Cluster RCTs - Pragmatic RCTs - Run in periods More to come in 2022 https://t.co/i7iTduDLUy